Section Arrow
CMRX.NASDAQ
- Chimerix
Quotes are at least 15-min delayed:2024/05/16 01:05 EDT
Last
 0.9775
-0.0225 (-2.25%)
Day High 
1.015 
Prev. Close
1-M High
1.05 
Volume 
121.15K 
Bid
0.98
Ask
1
Day Low
0.95 
Open
1.01 
1-M Low
0.88 
Market Cap 
89.63M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.98 
20-SMA 0.95 
50-SMA 1.02 
52-W High 1.57 
52-W Low 0.88 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.94/-1.07
Enterprise Value
90.93M
Balance Sheet
Book Value Per Share
1.94
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
324.00K
Operating Revenue Per Share
0.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed:2024/05/16 01:05 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.